Search Results 41-50 of 2021 for ❓ 172100:54 ❓텔레@admallsite❓❓온라인쇼핑❓❓❓텔레@admallsite❓❓❓쇼핑채널❓❓❓
This will help determine the safety and feasibility of using cell-based regenerative therapy as an additional treatment for the management of HLHS.
Study to Determine the Safety and Effectiveness of CLS-TA in Combination with an Intravitreal Anti-VEGF Agent in Subjects with Retinal Vein Occlusion · Overview.
In this study the investigators propose to use a daily dose of 45 mg (30 mg at 8 AM and 15 mg at 4 PM). This relatively small well-tolerated dose is likely to ...
The purose of this study is to develop assays to identify markers related to aging processes in a variety of biospecimens, including but limited to blood, urine ...
About this study. The purpose of this study is to evaluate patterns of and changes in secretion levels of the stress hormone, cortisol and other steroid ...
Patients transferred in to an UPSTREAM hospital are eligible for inclusion, but the timing for OAP agent administration and diagnostic catheterization begin ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
About this study. The purpose of this study is to study HIV infected individuals or others who have had another infection or inflammatory condition that may ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift that can go twice as far to advance healthcare research.